Recent Updates
Recently added Catalysts
CHE Positive Sentiment Score: 75/100

ITEM 991 Press Release for Amended Restated Credit Facility  CONTACT: Michael D. Witzeman FOR IMMEDIATE RELEASE (513) 762-6714  Chemed Corporation Announces a Five-Year $450 Million Amended and Restated C

Key Takeaway: Chemed Corporation announced an Amended and Restated Credit Agreement, securing a five-year revolving credit facility worth $450 million. The agreement includes a $100 million allocation for letters of credit and features a floating interest rate based on the secured overnight financing rate (SOFR). Additionally, Chemed can expand the facility by up to $250 million, enhancing its financial flexibility. The company operates two subsidiaries, VITAS Healthcare and Roto-Rooter, emphasizing its diversified business model. Investors are cautioned regarding the inherent risks associated with forward-looking statements about Chemed's performance.

Market Sentiment Analysis

POSITIVE FACTORS

  • Chemed secured a substantial $450 million revolving credit facility.
  • The agreement allows for an additional $250 million expansion, providing financial flexibility.
  • The collaboration with major banks like JPMorgan Chase and Bank of America supports credibility.

Full Press Release Details

CONTACT: Michael D. Witzeman FOR IMMEDIATE RELEASE
(513) 762-6714
Chemed Corporation Announces a Five-Year $450 Million
Amended and Restated Credit Agreement
CINCINNATI, April 13, 2026--Chemed Corporation ("Chemed") (NYSE:CHE) announced that it has entered into an Amended and Restated Credit Agreement for its Credit Facility ( Credit Agreement ). JPMorgan Chase Bank, N.A., acted as the Administrative Agent, Joint Lead Arranger and Joint Bookrunner for this transaction. Bank of America, N.A., was Joint Lead Arranger, Joint Bookrunner and Syndication Agent and PNC N.A. and U.S. Bank N.A. were Co-Documentation Agents.
Terms of the Credit Agreement consist of a five-year $450 million revolving credit facility including $100 million for letters of credit. The interest rate on this Credit Agreement has a floating rate that is generally the secured overnight financing rate ( SOFR ) plus an additional tiered rate which varies based on our current leverage ratio. The Credit Agreement includes an expansion feature that provides Chemed the opportunity to increase its revolver by an additional $250 million.
Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care and Roto-Rooter is the nation's leading provider of plumbing and drain cleaning services.
Statements in this press release or in other Chemed communications may relate to future events or Chemed's future performance. Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances. Investors are cautioned that such forward-looking statements are subject to inherent risk that actual results may differ materially from such forward-looking statements. Further, investors are cautioned that Chemed does not assume any obligation to update forward-looking statements based on unanticipated events or changed expectations.

Frequently Asked Questions

What is the amount of Chemed's amended credit facility?

Chemed's amended credit facility is $450 million.

Who acted as the Administrative Agent for Chemed's agreement?

JPMorgan Chase Bank, N.A. served as the Administrative Agent.

How long is the term for the credit agreement?

The term for the credit agreement is five years.

What companies does Chemed Corporation operate?

Chemed operates VITAS Healthcare and Roto-Rooter.

What type of care does VITAS Healthcare provide?

VITAS Healthcare is the largest provider of end-of-life hospice care.

Last updated: Apr 13, 2026